Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Chemotherapy in Children With T Cell and Pre-B Cell Non-Hodgkin's Lymphoma
NCT00003650Phase 3Completed
- Sponsor
- Unicancer
- Start
- Feb 1997
- Primary completion
- Dec 2008
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of asparaginase escherichia coli, cyclophosphamide, cytarabine, daunorubicin, mercaptopurine in non-Hodgkin lymphoma, T-cell, Precursor B-cell lymphoblastic lymphoma (B-LBL), sponsored by Unicancer. Started Feb 1997; status: completed.
02
Drugs
asparaginase escherichia colicyclophosphamidecytarabinedaunorubicinmercaptopurine
03
Conditions
non-Hodgkin lymphoma, T-cellPrecursor B-cell lymphoblastic lymphoma (B-LBL)
Beyond the preview
Go deeper on NCT00003650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003650.